Completed
A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001
NCT04540770
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Mackay Memorial Hospital New Taipei City, Taiwan
- National Taiwan University Hospital Taipei, Taiwan